Last: | $18.21 |
---|---|
Change Percent: | -0.17% |
Open: | $18 |
Close: | $18.21 |
High: | $18.62 |
Low: | $17.55 |
Volume: | 119,692 |
Last Trade Date Time: | 07/05/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$18.21 | $18 | $18.21 | $18.62 | $17.55 | 119,692 | 07-05-2024 |
$17.97 | $18.28 | $17.97 | $18.48 | $17.575 | 67,670 | 07-04-2024 |
$17.97 | $18.28 | $17.97 | $18.48 | $17.575 | 67,670 | 07-03-2024 |
$18.06 | $18.62 | $18.06 | $18.7025 | $17.8 | 299,212 | 07-02-2024 |
$18.74 | $18.78 | $18.74 | $19.205 | $18.705 | 156,576 | 07-01-2024 |
$19 | $20 | $19 | $20 | $18.95 | 290,651 | 06-28-2024 |
$19 | $18.36 | $19 | $19.58 | $18.36 | 480,273 | 06-27-2024 |
$18.31 | $19.68 | $18.31 | $19.68 | $18.11 | 188,099 | 06-26-2024 |
$19.95 | $20.08 | $19.95 | $20.9 | $19.72 | 90,094 | 06-25-2024 |
$20.36 | $19.65 | $20.36 | $21.005 | $19.3 | 230,164 | 06-24-2024 |
$19.65 | $18.96 | $19.65 | $19.785 | $18.73 | 333,900 | 06-21-2024 |
$18.9 | $19.5 | $18.9 | $19.865 | $18.01 | 233,762 | 06-20-2024 |
$18.9 | $19.22 | $18.9 | $19.505 | $18.23 | 105,978 | 06-19-2024 |
$18.9 | $19.22 | $18.9 | $19.505 | $18.23 | 105,978 | 06-18-2024 |
$19 | $19.18 | $19 | $19.31 | $17.24 | 121,100 | 06-17-2024 |
$19.3 | $19.37 | $19.3 | $19.86 | $18.97 | 45,370 | 06-14-2024 |
$19.72 | $20.59 | $19.72 | $21.375 | $19.53 | 95,466 | 06-13-2024 |
$20.8 | $20.85 | $20.8 | $21.8 | $20.54 | 61,542 | 06-12-2024 |
$20.85 | $20.81 | $20.85 | $21.75 | $20.5 | 55,807 | 06-11-2024 |
$20.79 | $20.22 | $20.79 | $20.81 | $20.16 | 100,658 | 06-10-2024 |
News, Short Squeeze, Breakout and More Instantly...
Silence Therapeutics Plc Company Name:
SLN Stock Symbol:
NASDAQ Market:
Silence Therapeutics Plc Website:
2024-06-28 10:00:07 ET Keay Nakae from Chardan Capital issued a price target of $55.00 for SLN on 2024-06-28 08:03:00. The adjusted price target was set to $55.00. At the time of the announcement, SLN was trading at $19. The overall price target consensus is at $48.33 wi...
2024-06-28 09:00:06 ET Michael Ulz from Morgan Stanley issued a price target of $49.00 for SLN on 2024-06-28 07:44:00. The adjusted price target was set to $49.00. At the time of the announcement, SLN was trading at $19. The overall price target consensus is at $38.00 wi...
Divesiran eliminated the need for phlebotomy in all well-controlled patients following infrequent dosing and was well tolerated Data support advancing divesiran into Phase 2 Company to host conference call today at 8:30am Eastern Time Silence Therapeutics plc (“Si...